avatar
zod***com05/30/2020 18:07

$Vyne Therapeutics Inc wasnt this drug FDA approved yesterday what am I missing The? What is June 2nd? "The FDA set a Prescription Drug User Fee Act action date of June 2nd, 2020.  If approved, FMX103 would be the first minocycline product available for rosacea patients. Foamix is also conducting a Phase II trial for FCD105, a topical combination foam of minocycline and adapalene, currently being evaluated for the treatment of moderate-to-severe acne vulgaris."

2
2
Disclaimer: The comments, opinions or any other information provided herein are from the users who are posting onto the Webull platform and not from Webull. The content provided by such users do not represent the opinion of Webull, and should not be construed as investment advice or recommendation, nor as an offer or solicitation to deal in any investment product. Investors should consider their investment objectives and risks carefully before investing. If in doubt, please seek advice from professional financial advisers. For more information, please refer to the Webull Community Agreement.
avatar
Share your ideas here…

All Comments

No data yet, let's see others
zod***com
7
Following
516
Post
0
Wefolios
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.

  • Copyright © 2026 Webull. All Rights Reserved